It has been another busy month reporting the latest bariatric and metabolic, and obesity-related disease news. We hope we have brought you the latest and most interesting news as it happened. Here are the Top 10 most read articles on Bariatric News in October 2022.
The International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) and the American Society for Metabolic and Bariatric Surgery (ASMBS) have published the first new guidelines of international, evidence-based guideline recommendations for bariatric and metabolic surgery (BMS) in over 30 years. The guidelines, ‘ASMBS/IFSO Guidelines on Indications for Metabolic and Bariatric Surgery - 2022’, were published in the journals Surgery for Obesity and Related Diseases (SOARD) and Obesity Surgery. The guidelines replace the 1991 consensus statement from the National Institutes of Health and include multiple changes, including expanding the patient population for metabolic and bariatric surgery to include patients with type 2 diabetes and a BMI of 30kg/m2 or greater.
The United Arab Emirates (UAE) has one of the highest obesity rates in the world, with 2017-18 data from the Global Obesity Observatory reporting that in the Emirati population 38.5% of men were living with overweight and 32.2% living with obesity and 29.3% of women living with overweight and 41.8% living with obesity1. Bariatric News spoke with Professor Safwan Taha, Director of the Metabolic and Bariatric Surgery Center, Center of Excellence in Metabolic and Bariatric Surgery (SRC; USA), Mediclinic Airport Road Hospital Abu Dhabi, UAE, about the causes of obesity, access to metabolic and bariatric surgery, the changing perspective of the community towards obesity and the role of the local authorities in the management of this globally growing problem.
Same-day discharge (SDD) after Roux-en-Y gastric bypass (RYGB) seems to be safe and has comparable outcomes to inpatients discharged on postoperative days on-two, according to researchers from the University of Illinois at Chicago, IL. They caution that as the number of SDD cases are increasing there is a need to standardised patient selection criteria and perioperative management protocols. The findings were featured in the paper, ‘Is Same-Day Discharge After Roux-en-Y Gastric Bypass Safe? A Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program Database Analysis’, published in Obesity Surgery.
The American Society of Metabolic and Bariatric Surgery (ASMBS) has published a consensus statement on laparoscopic adjustable gastric band (LAGB) management, that is replacing the existing American Society for Metabolic and Bariatric Surgery (ASMBS) LAGB adjustment credentialing guidelines for physician extenders with consensus statements that reflect the current state of LAGB management1. Reported in SOARD, the “American Society of Metabolic and Bariatric Surgery consensus statement on laparoscopic adjustable gastric band management”, was published in behalf of the ASMBS Integrated Health Clinical Issues Committee.
Laparoscopic adjustable gastric banding (LAGB) could play in a role in the creation of symptomatic hiatal hernias (HHs) however, further research is needed to underpin the mechanism and confirm causation, according to researchers from the Kingston Hospital NHS Foundation Trust and Queen Mary University of London, London, UK, Texas Tech University Health Sciences Center, Amarillo, USA and the University of Jordan, Amman, Jordan. However, stressed that HHs should potentially be discussed with patients opting for this kind of operation as it can be a reason for re-operation. The findings were featured in the paper, ‘Hiatus Hernia as a Complication of Gastric Banding: A Systematic Review and Meta-Analysis’, published in Cureus.
Researchers from the Ohio State University, Columbus, OH, have report that bariatric surgery, compared with nonsurgical care, was associated with significant reduction in cardiovascular disease (CVD) risk in individuals with severe obesity and Nonalcoholic Fatty Liver Disease (NAFLD).
A study has predicted that US$2.2 trillion could be saved annually if overweight and obesity (OAO) prevalence remained at 2019 levels. The study, ‘Economic impacts of overweight and obesity: current and future estimates for 161 countries’, analysed the current economic impact of overweight and obesity in 161 countries. It provides the first-ever country-specific global estimate of the economic impacts of the non-communicable disease (NCD), mainly due to avoidable healthcare costs of cancer, diabetes and cardiovascular disease attributable to obesity.
Data from a pan-European study on the burden of digestive diseases, presented today at United European Gastroenterology Week 2022 and published in the United European Gastroenterology Journal, highlights a worrying increase in the prevalence of several digestive diseases since 2000. These include chronic liver diseases, pancreatitis, gastroesophageal reflux disease, gastritis, vascular intestinal disorders and coeliac disease in children. In addition, the incidence and mortality rates for all digestive cancers combined have increased by 26% and 17% respectively in the period 2000–2019. The findings were featured in the paper, ‘Analysis of the burden and economic impact of digestive diseases and investigation of research gaps and priorities in the field of digestive health in the European Region - White Book 2: Executive summary’, published in the United European Gastroenterology Journal.
A team of international researchers have reported large vari ations in life expectancy for type 2 diabetics across 23 high-income countries with the lifetime risk of type 2 diabetes ranging from 16.3% for Scottish women to 59.6% for Singaporean men. They noted that despite declining lifetime risk and improvements in life expectancy for type 2 diabetics, the burden of type 2 diabetes “remains substantial”.
Body weight targets that stigmatise and potentially harm patients continue to be commonly used in everyday clinical practice, but are outdated and long overdue for change, according to a presentation at this year's International Congress on Obesity, Melbourne, Australia.